Objective: To describe proximal occlusion of a hydrosalpinx by hysteroscopic placement of a microinsert before IVF-ET.
Design: Case report.
Setting: Health maintenance organization and tertiary-care assisted reproductive technology unit.
Patient(s): Obese, infertile woman with pelvic adhesive disease and unilateral hydrosalpinx.
Intervention(s): Hysteroscopic placement of a microinsert into the proximal segment of a fallopian tube that was distally obstructed by hydrosalpinx. No intraoperative or postoperative complications occurred with hysteroscopic placement of microinsert.
Main Outcome Measure(s): Nonincisional proximal tubal occlusion under local anesthesia and intravenous sedation. Pregnancy by IVF-ET.
Result(s): No intraoperative or postoperative complications with hysteroscopic placement of microinsert were seen. After uterine transfer of three embryos, dichorionic-diamniotic twins were delivered by cesarean section at 34 weeks of gestation.
Conclusions(s): Hysteroscopic placement of a microinsert to proximally occlude a hydrosalpinx might be an alternative to laparoscopic proximal tubal occlusion or salpingectomy in patients with tubal disease planning IVF-ET.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.fertnstert.2004.10.056 | DOI Listing |
Cureus
December 2024
Obstetrics and Gynaecology, Khyber Teaching Hospital, Peshawar, PAK.
Background Hysteroscopy, a minimally invasive procedure for diagnosing and treating intrauterine pathologies, can be challenging due to inadequate cervical dilation, leading to procedural difficulties and patient discomfort. Misoprostol, a synthetic prostaglandin E1 analog, is increasingly used for cervical ripening to ease hysteroscopic procedures. Objective To evaluate the efficacy and safety of misoprostol for cervical ripening prior to hysteroscopy.
View Article and Find Full Text PDFFront Pharmacol
December 2024
Department of Anesthesiology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Background: The combination of esketamine and propofol has become a common choice for total intravenous anesthesia in hysteroscopic procedures. However, the optimal effective dose has not yet been determined. The aim of this study was to determine the median effective dose (ED) and 95% effective dose (ED) of esketamine compounded with propofol for painless hysteroscopy.
View Article and Find Full Text PDFFacts Views Vis Obgyn
December 2024
Background: The Adiana® Permanent Contraception System was a hysteroscopic tubal occlusion device but was withdrawn from the market in 2012.
Objective: To evaluate the safety, feasibility and efficacy of the Adiana hysteroscopic tubal occlusion.
Materials And Methods: A prospective observational multicentre cohort study of 300 women undergoing hysteroscopic sterilisation using the Adiana® was conducted in the Netherlands between 2009 and 2012.
J Neurosurg Case Lessons
November 2024
Departments of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Am J Transl Res
October 2024
Department of Gynaecology, Xianyang Maternal and Child Health Hospital Century Avenue, Qindu District, Xianyang 712000, Shaanxi, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!